Literature DB >> 35102280

The role of ROS in tumour development and progression.

Eric C Cheung1, Karen H Vousden2.   

Abstract

Eukaryotic cells have developed complex systems to regulate the production and response to reactive oxygen species (ROS). Different ROS control diverse aspects of cell behaviour from signalling to death, and deregulation of ROS production and ROS limitation pathways are common features of cancer cells. ROS also function to modulate the tumour environment, affecting the various stromal cells that provide metabolic support, a blood supply and immune responses to the tumour. Although it is clear that ROS play important roles during tumorigenesis, it has been difficult to reliably predict the effect of ROS modulating therapies. We now understand that the responses to ROS are highly complex and dependent on multiple factors, including the types, levels, localization and persistence of ROS, as well as the origin, environment and stage of the tumours themselves. This increasing understanding of the complexity of ROS in malignancies will be key to unlocking the potential of ROS-targeting therapies for cancer treatment.
© 2022. Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35102280     DOI: 10.1038/s41568-021-00435-0

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  274 in total

Review 1.  Cellular mechanisms and physiological consequences of redox-dependent signalling.

Authors:  Kira M Holmström; Toren Finkel
Journal:  Nat Rev Mol Cell Biol       Date:  2014-06       Impact factor: 94.444

Review 2.  The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance.

Authors:  J D Hayes; D J Pulford
Journal:  Crit Rev Biochem Mol Biol       Date:  1995       Impact factor: 8.250

Review 3.  Regulation of redox balance in cancer and T cells.

Authors:  Hyewon Kong; Navdeep S Chandel
Journal:  J Biol Chem       Date:  2017-12-27       Impact factor: 5.157

4.  NADPH production by the oxidative pentose-phosphate pathway supports folate metabolism.

Authors:  Li Chen; Zhaoyue Zhang; Atsushi Hoshino; Henry D Zheng; Michael Morley; Zoltan Arany; Joshua D Rabinowitz
Journal:  Nat Metab       Date:  2019-03-11

Review 5.  The role of glutathione-S-transferase in anti-cancer drug resistance.

Authors:  Danyelle M Townsend; Kenneth D Tew
Journal:  Oncogene       Date:  2003-10-20       Impact factor: 9.867

Review 6.  Mitochondrial generation of free radicals and hypoxic signaling.

Authors:  Robert O Poyton; Kerri A Ball; Pablo R Castello
Journal:  Trends Endocrinol Metab       Date:  2009-09-03       Impact factor: 12.015

Review 7.  Hydrogen peroxide reactivity and specificity in thiol-based cell signalling.

Authors:  Christine C Winterbourn
Journal:  Biochem Soc Trans       Date:  2020-06-30       Impact factor: 5.407

Review 8.  ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis.

Authors:  Benoît D'Autréaux; Michel B Toledano
Journal:  Nat Rev Mol Cell Biol       Date:  2007-10       Impact factor: 94.444

9.  Quantitative flux analysis reveals folate-dependent NADPH production.

Authors:  Jing Fan; Jiangbin Ye; Jurre J Kamphorst; Tomer Shlomi; Craig B Thompson; Joshua D Rabinowitz
Journal:  Nature       Date:  2014-05-04       Impact factor: 49.962

Review 10.  NADPH homeostasis in cancer: functions, mechanisms and therapeutic implications.

Authors:  Huai-Qiang Ju; Jin-Fei Lin; Tian Tian; Dan Xie; Rui-Hua Xu
Journal:  Signal Transduct Target Ther       Date:  2020-10-07
View more
  17 in total

1.  Decreased Levels of GSH Are Associated with Platinum Resistance in High-Grade Serous Ovarian Cancer.

Authors:  Daniela Criscuolo; Rosario Avolio; Matteo Parri; Simona Romano; Paola Chiarugi; Danilo Swann Matassa; Franca Esposito
Journal:  Antioxidants (Basel)       Date:  2022-08-10

Review 2.  High-Dose Vitamin C for Cancer Therapy.

Authors:  Ali Mussa; Ros Akmal Mohd Idris; Naveed Ahmed; Suhana Ahmad; Ahmad Hafiz Murtadha; Tengku Ahmad Damitri Al Astani Tengku Din; Chan Yean Yean; Wan Faiziah Wan Abdul Rahman; Norhafiza Mat Lazim; Vuk Uskoković; Khalid Hajissa; Noor Fatmawati Mokhtar; Rohimah Mohamud; Rosline Hassan
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-03

3.  Orobanche crenata Forssk. Extract Affects Human Breast Cancer Cell MCF-7 Survival and Viral Replication.

Authors:  Carlo Genovese; Adriana Garozzo; Floriana D'Angeli; Giuseppe Antonio Malfa; Francesco Bellia; Barbara Tomasello; Daria Nicolosi; Roberta Malaguarnera; Simone Ronsisvalle; Fiorella Guadagni; Rosaria Acquaviva
Journal:  Cells       Date:  2022-05-19       Impact factor: 7.666

Review 4.  Friend or Foe: The Relativity of (Anti)oxidative Agents and Pathways.

Authors:  András Szarka; Tamás Lőrincz; Péter Hajdinák
Journal:  Int J Mol Sci       Date:  2022-05-06       Impact factor: 6.208

Review 5.  TRIM family contribute to tumorigenesis, cancer development, and drug resistance.

Authors:  Ning Huang; Xiaolin Sun; Peng Li; Xin Liu; Xuemei Zhang; Qian Chen; Hong Xin
Journal:  Exp Hematol Oncol       Date:  2022-10-19

6.  Cyclic Hypoxia Induces Transcriptomic Changes in Mast Cells Leading to a Hyperresponsive Phenotype after FcεRI Cross-Linking.

Authors:  Deisy Segura-Villalobos; Monica Lamas; Claudia González-Espinosa
Journal:  Cells       Date:  2022-07-19       Impact factor: 7.666

Review 7.  Metabolic Adaptation-Mediated Cancer Survival and Progression in Oxidative Stress.

Authors:  Yongquan Tang; Zhe Zhang; Yan Chen; Siyuan Qin; Li Zhou; Wei Gao; Zhisen Shen
Journal:  Antioxidants (Basel)       Date:  2022-07-05

Review 8.  Effects of TP53 Mutations and miRs on Immune Responses in the Tumor Microenvironment Important in Pancreatic Cancer Progression.

Authors:  James A McCubrey; Li V Yang; Stephen L Abrams; Linda S Steelman; Matilde Y Follo; Lucio Cocco; Stefano Ratti; Alberto M Martelli; Giuseppa Augello; Melchiorre Cervello
Journal:  Cells       Date:  2022-07-09       Impact factor: 7.666

Review 9.  Effects and Mechanisms of Curcumin for the Prevention and Management of Cancers: An Updated Review.

Authors:  Zhi-Jun Yang; Si-Yu Huang; Dan-Dan Zhou; Ruo-Gu Xiong; Cai-Ning Zhao; Ai-Ping Fang; Yun-Jian Zhang; Hua-Bin Li; Hui-Lian Zhu
Journal:  Antioxidants (Basel)       Date:  2022-07-28

Review 10.  Metabolic reprogramming: a bridge between aging and tumorigenesis.

Authors:  Stanislav Drapela; Didem Ilter; Ana P Gomes
Journal:  Mol Oncol       Date:  2022-06-19       Impact factor: 7.449

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.